DR. MUHAMMAD BILAL MUNIR M.D.
Prescription History 1447505607
Internal Medicine - Cardiovascular Disease in Sacramento, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. MUHAMMAD BILAL MUNIR M.D., an active Cardiovascular Disease specialist practicing in Sacramento, CA. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 127 documented patient claims. Among these therapy options, the most frequently utilized medication is Eliquis, which accounts for 42 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other CA PrescribersVs. CA Avg |
|---|---|---|---|
| EliquisApixaban | 42 | $1,404.56 | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. In 2023, this provider wrote 42 Medicare prescriptions for Eliquis, about 62% of the volume of the typical California prescriber of this medication (68). Medicare paid an average of $1,404.56 per fill, versus $848.49 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 103 30-Day Fills standardized to 30-day supplies 3,090 Days of Medication total across all patients in 2023 | |||
| XareltoRivaroxaban | 32 | $765.59▼ below CA avg | ▼ Less than typical |
About Xarelto: Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. Show more ▾ It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban may be used in children to prevent blood clots from forming after a certain heart surgery (Fontan procedure). Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood. A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. In 2023, this provider wrote 32 Medicare prescriptions for Xarelto, about 73% of the volume of the typical California prescriber of this medication (44). Medicare paid an average of $765.59 per fill, versus $907.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 42 30-Day Fills standardized to 30-day supplies 1,260 Days of Medication total across all patients in 2023 | |||
| Amiodarone Hcl | 22 | $30.02▼ below CA avg | ▼ Less than typical |
About Amiodarone Hcl: This medication is used to treat certain types of serious (possibly fatal) irregular heartbeat (such as recurrent ventricular fibrillation/tachycardia). Show more ▾ It is used to restore normal heart rhythm and maintain a regular, steady heartbeat. Amiodarone is known as an anti-arrhythmic drug. It works by blocking certain electrical signals in the heart that can cause an irregular heartbeat. In 2023, this provider wrote 22 Medicare prescriptions for Amiodarone Hcl, about half the volume of the typical California prescriber of this medication (41). Medicare paid an average of $30.02 per fill, versus $36.08 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 52.5 30-Day Fills standardized to 30-day supplies 1,574 Days of Medication total across all patients in 2023 | |||
| Metoprolol Succinate | 20 | $19.16▼ below CA avg | ▼ Less than typical |
About Metoprolol Succinate: This medication is a beta-blocker used to treat chest pain (angina), heart failure, and high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This drug works by blocking the action of certain natural chemicals in your body (such as epinephrine) that affect the heart and blood vessels. This lowers heart rate, blood pressure, and strain on the heart. A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. In 2023, this provider wrote 20 Medicare prescriptions for Metoprolol Succinate, about a quarter of the volume of the typical California prescriber of this medication (82). Medicare paid an average of $19.16 per fill, versus $20.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 56 30-Day Fills standardized to 30-day supplies 1,660 Days of Medication total across all patients in 2023 | |||
| MultaqDronedarone Hcl | 11 | $822.99▼ below CA avg | ▼ Less than typical |
About Multaq: This medication is used if you have had certain types of irregular heartbeat (paroxysmal or persistent atrial fibrillation) in the past but now have a normal heart rhythm. Show more ▾ It helps you keep a normal heart rhythm and lowers your chance of having to go to the hospital for atrial fibrillation. Dronedarone is known as an antiarrhythmic drug. This medication should not be used if you have permanent atrial fibrillation because of the increased risk of very serious side effects. See also Warning section. A non-iodinated derivative of amiodarone that is used for the treatment of ARRHYTHMIA. In 2023, this provider wrote 11 Medicare prescriptions for Multaq, about a third of the volume of the typical California prescriber of this medication (31). Medicare paid an average of $822.99 per fill, versus $1,252.71 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 11 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. MUHAMMAD BILAL MUNIR M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Cardiovascular Disease prescribing approach at this Sacramento, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among CA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
